Neurology

The Pharmacy Times® Neurology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?

Ozanimod: Treatment for Relapsing Forms of Multiple Sclerosis

Ozanimod (Zeposia) became the third oral S1P modulator approved by the FDA for the treatment of multiple sclerosis,

New Blood Test Shows Great Promise in Diagnosis of Alzheimer Disease

A new blood test for Alzheimer disease could provide a more sensitive, accurate indicator of plaques and tangles corresponding to the disease in living people.

New Treatment Granted FDA Approval for Spinal Muscular Atrophy in Adults, Children

Risdiplam is the first at-home, orally administered treatment for spinal muscular atrophy in adults and children aged 2 months and older.

Study Finds Mental Fatigue of Multiple Sclerosis Impacts Brain Activation Patterns

Research may address the lack of effective treatments for mental fatigue among patients with multiple sclerosis.

Phase 4 Nusinersen Trial Underway in Infants, Children With Spinal Muscular Atrophy

Spinal muscular atrophy is the leading genetic cause of death in infants.

FDA Approves Zydus Cadila for Butalbital, Acetaminophen, and Caffeine Tablets

The combination medication is used to treat the symptoms of tension or muscle contraction headaches. The drug is only available via a prescription from a physician.

Newly Uncovered Molecules Reveal Potential Treatments for Epilepsy

New molecules could the brain’s immune system to better control epilepsy.

Drug for Rare Form of ALS Shows Promise

Tofersen proves safe in clinical trials in the treatment of amyotrophic lateral sclerosis.

Study: Health Care Professionals Vary in Their Beliefs About Medicinal Cannabis Use

The study concluded that pharmacists reportedly scored higher on the knowledge test than neurologists and nurse practitioners.

Challenges of Channel Management for Specialty: Medical Benefit or Pharmacy Benefit

Regardless of the channel through which a specialty medication is billed and filled, management strategies will be an essential cornerstone to controlling costs.

Tanezumab Relieves Chronic Low Back Pain in Large, International Study

Low back pain is one of the leading reasons people seek medical care and the number 1 cause of disability globally.

Multiple Sclerosis Has Multiple Treatment Options

The key to better outcomes for patients with MS is to address it early.

The Pharmacy Times® Neurology resource center provides a home for all of the latest clinical information that both neurologists and pharmacists that work within the field could find valuable. With articles covering updates from the robust pipeline of novel neurological therapies, and the newest data from all phases of clinical trials and studies in the space, it also serves as a hub of coverage from ongoing conferences and annual meetings of neurological associations.